Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy

Karla Sánchez-Lara, Ricardo Sosa-Sánchez, Dan Green-Renner, Cindy Rodríguez, Alessandro Laviano, Daniel Motola-Kuba, Oscar Arrieta, Karla Sánchez-Lara, Ricardo Sosa-Sánchez, Dan Green-Renner, Cindy Rodríguez, Alessandro Laviano, Daniel Motola-Kuba, Oscar Arrieta

Abstract

Objectives: To determine the relationship between energy and nutrient consumption with chemosensory changes in cancer patients under chemotherapy.

Methods: We carried out a cross-sectional study, enrolling 60 subjects. Cases were defined as patients with cancer diagnosis after their second chemotherapy cycle (n = 30), and controls were subjects without cancer (n = 30). Subjective changes of taste during treatment were assessed. Food consumption habits were obtained with a food frequency questionnaire validated for Mexican population. Five different concentrations of three basic flavors --sweet (sucrose), bitter (urea), and a novel basic taste, umami (sodium glutamate)-- were used to measure detection thresholds and recognition thresholds (RT). We determine differences between energy and nutrient consumption in cases and controls and their association with taste DT and RT.

Results: No demographic differences were found between groups. Cases showed higher sweet DT (6.4 vs. 4.4 micromol/ml; p = 0.03) and a higher bitter RT (100 vs. 95 micromol/ml; p = 0.04) than controls. Cases with sweet DT above the median showed significant lower daily energy (2,043 vs.1,586 kcal; p = 0.02), proteins (81.4 vs. 54 g/day; p = 0.01), carbohydrates (246 vs.192 g/day; p = 0.05), and zinc consumption (19 vs.11 mg/day; p = 0.01) compared to cases without sweet DT alteration. Cases with sweet DT and RT above median were associated with lower completion of energy requirements and consequent weight loss. There was no association between flavors DT or RT and nutrient ingestion in the control group.

Conclusion: Changes of sweet DT and bitter RT in cancer patients under chemotherapy treatment were associated with lower energy and nutrient ingestion. Taste detection and recognition thresholds disorders could be important factors in malnutrition development on patients with cancer under chemotherapy treatment.

References

    1. Wu GH, Liu ZH, Wu ZH, Wu ZG. Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J Gastroenterol. 2006;12(15):2441–2444.
    1. Oria EPE, Zugasti A. problemas agudos de la nutrición en el paciente oncológico. An Sist Sanit Navar. 2004;27:77–85.
    1. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998;11:48–51. doi: 10.1002/(SICI)1097-0215(1998)78:11+<48::AID-IJC14>;2-3.
    1. Huhmann MB, Cunningham RS. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol. 2005;6(5):334–343. doi: 10.1016/S1470-2045(05)70170-4.
    1. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs. 2005;9(Suppl 2):S84–91. doi: 10.1016/j.ejon.2005.09.003.
    1. Schiffman SS, Sattely-Miller EA, Taylor EL, Graham BG, Landerman LR, Zervakis J, Campagna LK, Cohen HJ, Blackwell S, Garst JL. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. The journal of nutrition, health & aging. 2007;11(5):439–454.
    1. Mattes RD, Cowart BJ. Dietary assessment of patients with chemosensory disorders. Journal of the American Dietetic Association. 1994;94(1):50–56. doi: 10.1016/0002-8223(94)92041-9.
    1. Schiffman SSWE. Contribution of taste and smell losses to the wasting syndrome. Age Nutr. 1996;7:106–120.
    1. Minakata Y, Yamagata T, Nakanishi H, Nishimoto T, Nakanishi M, Mune M, Yukawa S. Severe gustatory disorder caused by cisplatin and etoposide. International journal of clinical oncology/Japan Society of Clinical Oncology. 2002;7(2):124–127.
    1. DeWys. Abnormalities of taste as a remote effect of neoplasm. Ann NY Acad Sci. 1974;230:427–434. doi: 10.1111/j.1749-6632.1974.tb14476.x.
    1. Sherry VW. Taste alterations among patients with cancer. Clinical journal of oncology nursing. 2002;6(2):73–77. doi: 10.1188/02.CJON.73-77.
    1. Barale K, Aker SN, Martinsen CS. Primary taste thresholds in children with leukemia undergoing marrow transplantation. JPEN J Parenter Enteral Nutr. 1982;6(4):287–290. doi: 10.1177/0148607182006004287.
    1. Bartoshuk LM. Chemosensory alterations and cancer therapies. NCI Monogr. 1990. pp. 179–184.
    1. Bromley SM. Smell and taste disorders: a primary care approach. American family physician. 2000;61(2):427–436.
    1. Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer. 2008;16(3):275–283. doi: 10.1007/s00520-007-0319-7.
    1. Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer. 2001;9(8):575–580. doi: 10.1007/s005200100279.
    1. Small DMZD. Human cortical gustatory areas: a review of functional neuroimaging data. Neuroreport. 1999;10:7–14. doi: 10.1097/00001756-199901180-00002.
    1. Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, Potter C, Blendowski C. Taste changes experienced by patients receiving chemotherapy. Oncology nursing forum. 1999;26(4):697–706.
    1. Strasser F, Demmer R, Bohme C, Schmitz SF, Thuerlimann B, Cerny T, Gillessen S. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. The oncologist. 2008;13(3):337–346. doi: 10.1634/theoncologist.2007-0217.
    1. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2002;30(11):785–792. doi: 10.1038/sj.bmt.1703716.
    1. Welge-Lussen A, Gudziol H. [Etiology, diagnostic and therapeutic management of taste disorders] Ther Umsch. 2004;61(5):302–307. doi: 10.1024/0040-5930.61.5.302.
    1. Halyard MY. Taste and smell alterations in cancer patients--real problems with few solutions. The journal of supportive oncology. 2009;7(2):68–69.
    1. ET R. Basic Characteristics of Glutamates and Umami Sensing in the Oral Cavity and Gut. J Nutr. 2000;130:960S–965S.
    1. Shi HB, Masuda M, Umezaki T, Kuratomi Y, Kumamoto Y, Yamamoto T, Komiyama S. Irradiation impairment of umami taste in patients with head and neck cancer. Auris, nasus, larynx. 2004;31(4):401–406. doi: 10.1016/j.anl.2004.05.002.
    1. Redda MGAS. Radiotherapy-induced taste impairment. Cancer treatment reviews. 2006;32:541–547. doi: 10.1016/j.ctrv.2006.06.003.
    1. Shadan S. Molecular biology: A taste of umami. Nature. 2009;457(7226):160. doi: 10.1038/457160a.
    1. Toyama K, Tomoe M, Inoue Y, Sanbe A, Yamamoto S. A possible application of monosodium glutamate to nutritional care for elderly people. Biological & pharmaceutical bulletin. 2008;31(10):1852–1854. doi: 10.1248/bpb.31.1852.
    1. Hernandez-Avila M, Romieu IPS, Hernandez-Avila J, Madrigal H, Willet W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998;40:133-140. Salud Publica Mex. 1998;40:133–140.
    1. Carson JA, Gormican A. Taste acuity and food attitudes of selected patients with cancer. Journal of the American Dietetic Association. 1977;70(4):361–365.
    1. Williams LR, Cohen MH. Altered taste thresholds in lung cancer. The American journal of clinical nutrition. 1978;31(1):122–125.
    1. Markley EJM-KD, Henkin RI. A classification of dysgeusia. Journal of the American Dietetic Association. 1983;83:578–580.
    1. Schiffman SS. Taste and smell in disease (first of two parts) The New England journal of medicine. 1983;308(21):1275–1279.
    1. Schiffman SS. Taste and smell in disease (second of two parts) The New England journal of medicine. 1983;308(22):1337–1343.
    1. Nakazato Y, Imai K, Abe T, Tamura N, Shimazu K. Unpleasant sweet taste: a symptom of SIADH caused by lung cancer. J Neurol Neurosurg Psychiatry. 2006;77(3):405–406. doi: 10.1136/jnnp.2005.073726.
    1. Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. Journal of pain and symptom management. 2007;33(2):156–165. doi: 10.1016/j.jpainsymman.2006.07.017.
    1. Berteretche MV, Dalix AM, d'Ornano AM, Bellisle F, Khayat D, Faurion A. Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer. 2004;12(8):571–576. doi: 10.1007/s00520-004-0589-2.
    1. Trant A, S SJ, Douglas HO. Is taste related to anorexia in cancer patients? The American journal of clinical nutrition. 1982;36:45–58.
    1. Mattes-Kulig DA, Henkin RI. Energy and nutrient consumption of patients with dysgeusia. Journal of the American Dietetic Association. 1985;85(7):822–826.
    1. Bernhardson BMTC, Rutqvist LE. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. Journal of pain and symptom management. 2007;34:403–412. doi: 10.1016/j.jpainsymman.2006.12.010.
    1. Holmes S. Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer. 1993;1(6):326–330. doi: 10.1007/BF00364971.
    1. Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. The American journal of the medical sciences. 1976;272(3):285–299. doi: 10.1097/00000441-197611000-00006.
    1. Ripamonti C, Zecca E, Brunelli C, Fulfaro F, Villa S, Balzarini A, Bombardieri E, De Conno F. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer. 1998;82(10):1938–1945. doi: 10.1002/(SICI)1097-0142(19980515)82:10<1938::AID-CNCR18>;2-U.
    1. Stoll AL, Oepen G. Zinc salts for the treatment of olfactory and gustatory symptoms in psychiatric patients: a case series. The Journal of clinical psychiatry. 1994;55(7):309–311.
    1. Fukasawa T, Orii T, Tanaka M, Suzuki N, Kanzaki Y. Relation between drug-induced taste disorder and chelating behavior with zinc ion; statistical approach to the drug-induced taste disorder, part II. Chemical & pharmaceutical bulletin. 2008;56(8):1177–1180. doi: 10.1248/cpb.56.1177.
    1. Heyneman CA. Zinc deficiency and taste disorders. The Annals of pharmacotherapy. 1996;30(2):186–187.
    1. Nakata Y, Hirashima T, Kondou Y, Tokuoka Y, Imazato H, Iwata K, Oomori Y, Yamato A, Shimizu S, Nagao S. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)] Gan to kagaku ryoho. 2008;35(6):955–959.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere